ROBINSON JAMES GEORGE purchased 0.3% of their position (10K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $151.6K — a small addition. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 7/1/2019ACC: 0001651844-19-000018
Director
Since Oct 2018
+10K
Net shares
Net buyer
$151.6K
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
10K acquired
Non-Derivative Transactions6
Common Stock
Direct
Shares
+1.11K
Price / share
$1.48
Trade value
$1.64K
% of position
0.0%
6/28/2019
3.46M→3.46M
Common Stock
Direct
Shares
+3.15K
Price / share
$1.52
Trade value
$4.80K
% of position
0.1%
6/29/2019
3.46M→3.46M
Common Stock
Direct
Shares
+920.00
Price / share
$150.00
Trade value
$138K
% of position
0.0%
6/29/2019
3.46M→3.47M
Common Stock
Direct
Shares
+1K
Price / share
$1.49
Trade value
$1.49K
% of position
0.0%
6/29/2019
3.47M→3.47M
Common Stock
Direct
Shares
+3.02K
Price / share
$1.48
Trade value
$4.46K
% of position
0.1%
6/29/2019
3.47M→3.47M
Common Stock
Direct
Shares
+800.00
Price / share
$1.48
Trade value
$1.18K
% of position
0.0%
6/29/2019
3.47M→3.47M
Total
Net shares
+10K
Net value
$151.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/28/2019 | P · Purchase | +1.11K | $1.48 | $1.64K | 0.0% | 3.46M | 3.46M |
| Common Stock Direct | 6/29/2019 | P · Purchase | +3.15K | $1.52 | $4.80K | 0.1% | 3.46M | 3.46M |
| Common Stock Direct | 6/29/2019 | P · Purchase | +920.00 | $150.00 | $138K | 0.0% | 3.46M | 3.47M |
| Common Stock Direct | 6/29/2019 | P · Purchase | +1K | $1.49 | $1.49K | 0.0% | 3.47M | 3.47M |
| Common Stock Direct | 6/29/2019 | P · Purchase | +3.02K | $1.48 | $4.46K | 0.1% | 3.47M | 3.47M |
| Common Stock Direct | 6/29/2019 | P · Purchase | +800.00 | $1.48 | $1.18K | 0.0% | 3.47M | 3.47M |
| Total | +10K | $151.57K | ||||||
Derivative Transactions0
No derivative transactions reported